Tumor MGMT promoter hypermethylation changes over time limit temozolomide efficacy in a phase II trial for metastatic colorectal cancer

Annals of Oncology

from Gastroenterology via xlomafota13 on Inoreader http://ift.tt/1pPRMMc
via IFTTT